The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan.
Open accessAbstract
Treatment of human fibroblasts with human recombinant gamma interferon blocked the growth of Toxoplasma gondii, an obligate intracellular protozoan parasite. Growth of the parasite was measured by a plaque assay 7 days after infection or by the incorporation of [3H]uracil 1 or 2 days after infection. The antitoxoplasma activity induced in the host cells by gamma interferon was strongly dependent upon the tryptophan concentration of the medium. Progressively higher minimal inhibitory concentrations of gamma interferon were observed as the tryptophan concentration in the culture medium was increased. Treatment with gamma interferon did not make the cells impermeable to tryptophan. The kinetics of [3H]tryptophan uptake into the acid-soluble pools of control and gamma interferon-treated cultures were identical during the first 48 sec. Thereafter uptake of [3H]tryptophan into the acid-soluble pool of control fibroblasts reached the expected plateau after 96 sec. In contrast, uptake of [3H]tryptophan continued for at least 12 min in the gamma interferon-treated cultures. At that time, the acid-soluble pool of the gamma interferon-treated cultures contained 8 times the radioactivity of the control cultures. This continued accumulation was the result of rapid intracellular degradation of [3H]tryptophan into kynurenine and N-formylkynurenine that leaked slowly from the cells. These two metabolites were also recovered from the medium of cultures treated for 1 or 2 days with gamma interferon. Human recombinant alpha and beta interferons, which have no antitoxoplasma activity, did not induce any detectable degradation of tryptophan. Several hypotheses are presented to explain how the intracellular degradation of tryptophan induced by gamma interferon could restrict the growth of an obligate intracellular parasite.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nutrition Needs of Mammalian Cells in Tissue Culture
Eagle, H. (1955) · Science · doi:10.1126/science.122.3168.501 · Cited by 1,619
Expression of human immune interferon cDNA in E. coli and monkey cells
Gray, P. W., Leung, D. W., Pennica, D., Yelverton, E., Najarian, R., Simonsen, C. C., Derynck, R., Sherwood, P. J., Wallace, D. M., Berger, S. L., et al. (1982) · Nature · doi:10.1038/295503a0 · Cited by 689
Plaque production by the polyoma virus
Dulbecco, R., & Freeman, G. (1959) · Virology · doi:10.1016/0042-6822(59)90043-1 · Cited by 672
Spector, W. S. (1957) · AIBS Bulletin · doi:10.2307/1292070 · Cited by 342
Induction of pulmonary indoleamine 2,3-dioxygenase by interferon.
Yoshida, R., Imanishi, J., Oku, T., Kishida, T., & Hayaishi, O. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.1.129 · Cited by 292
Weil, J., Epstein, C. J., Epstein, L. B., Sedmak, J. J., Sabran, J. L., & Grossberg, S. E. (1983) · Nature · doi:10.1038/301437a0 · Cited by 228
Toxoplasma gondii: Isolation and preliminary characterization of temperature-sensitive mutants
Pfefferkorn, E. R., & Pfefferkorn, L. G. (1976) · Experimental Parasitology · doi:10.1016/0014-4894(76)90040-0 · Cited by 203
Self-citationEFFECT OF NORMAL AND ACTIVATED HUMAN MACROPHAGES ON TOXOPLASMA GONDII
Anderson, S. E., & Remington, J. S. (1974) · The Journal of Experimental Medicine · doi:10.1084/jem.139.5.1154 · Cited by 155
Interferon: Protection of Cells Infected with an Intracellular Protozoan ( Toxoplasma gondii )
Remington, J. S., & Merigan, T. C. (1968) · Science · doi:10.1126/science.161.3843.804 · Cited by 112
Toxoplasma gondii: The enzymic defect of a mutant resistant to 5-fluorodeoxyuridine
Pfefferkorn, E. R. (1978) · Experimental Parasitology · doi:10.1016/0014-4894(78)90077-2 · Cited by 76
Self-citation
Cited by
Interferon-γ: an overview of signals, mechanisms and functions
Schroder, K., Hertzog, P. J., Ravasi, T., & Hume, D. A. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0603252 · Cited by 4,120
A guide to immunometabolism for immunologists
O'Neill, L. A. J., Kishton, R. J., & Rathmell, J. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.70 · Cited by 3,315
CELLULAR RESPONSES TO INTERFERON-γ
Boehm, U., Klamp, T., Groot, M., & Howard, J. C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.749 · Cited by 2,890
Ido expression by dendritic cells: tolerance and tryptophan catabolism
Mellor, A. L., & Munn, D. H. (2004) · Nature Reviews Immunology · doi:10.1038/nri1457 · Cited by 2,341
Epidemiology of and Diagnostic Strategies for Toxoplasmosis
Robert-Gangneux, F., & Dardé, M.-L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05013-11 · Cited by 1,815
Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism
Munn, D. H., Shafizadeh, E., Attwood, J. T., Bondarev, I., Pashine, A., & Mellor, A. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.9.1363 · Cited by 1,623
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
Platten, M., Nollen, E. A. A., Röhrig, U. F., Fallarino, F., & Opitz, C. A. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0016-5 · Cited by 1,586
Amino acids and immune function
Li, P., Yin, Y.-L., Li, D., Woo Kim, S., & Wu, G. (2007) · British Journal of Nutrition · doi:10.1017/s000711450769936x · Cited by 1,584
Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
Castro, F., Cardoso, A. P., Gonçalves, R. M., Serre, K., & Oliveira, M. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00847 · Cited by 1,224
Interferon-γ: the Major Mediator of Resistance Against Toxoplasma gondii
Suzuki, Y., Orellana, M. A., Schreiber, R. D., & Remington, J. S. (1988) · Science · doi:10.1126/science.3128869 · Cited by 1,173
Luster, A. D., Unkeless, J. C., & Ravetch, J. V. (1985) · Nature · doi:10.1038/315672a0 · Cited by 944
Terness, P., Bauer, T. M., Röse, L., Dufter, C., Watzlik, A., Simon, H., & Opelz, G. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020052 · Cited by 937
Munn, D. H., Sharma, M. D., Hou, D., Baban, B., Lee, J. R., Antonia, S. J., Messina, J. L., Chandler, P., Koni, P. A., & Mellor, A. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21583 · Cited by 852
Interaction of chlamydiae and host cells in vitro
Moulder, J. W. (1991) · Microbiological Reviews · doi:10.1128/mmbr.55.1.143-190.1991 · Cited by 820
Endogenous kynurenines as targets for drug discovery and development
Stone, T. W., & Darlington, L. G. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd870 · Cited by 768
Tryptophan and the immune response
Moffett, J. R., & Namboodiri, M. A. (2003) · Immunology & Cell Biology · doi:10.1046/j.1440-1711.2003.t01-1-01177.x · Cited by 760
Regulation and Function of T-Cell-Mediated Immunity during Toxoplasma gondii Infection
Denkers, E. Y., & Gazzinelli, R. T. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.4.569 · Cited by 701
Kynurenine Pathway Metabolites in Humans: Disease and Healthy States
Chen, Y., & Guillemin, G. J. (2009) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s2097 · Cited by 628
The interferon system. A bird's eye view of its biochemistry.
Sen, G. C., & Lengyel, P. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42719-6 · Cited by 620
Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis
Beatty, W. L., Morrison, R., & Byrne, G. I. (1994) · Microbiological Reviews · doi:10.1128/mmbr.58.4.686-699.1994 · Cited by 588
Interferon-inducible effector mechanisms in cell-autonomous immunity
MacMicking, J. D. (2012) · Nature Reviews Immunology · doi:10.1038/nri3210 · Cited by 579
Modulation of innate immunity by Toxoplasma gondii virulence effectors
Hunter, C. A., & Sibley, L. D. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2858 · Cited by 570
Tryptophan metabolism, from nutrition to potential therapeutic applications
Le Floc’h, N., Otten, W., & Merlot, E. (2011) · Amino Acids · doi:10.1007/s00726-010-0752-7 · Cited by 561
Monitoring tryptophan metabolism in chronic immune activation
Schröcksnadel, K., Wirleitner, B., Winkler, C., & Fuchs, D. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.06.013 · Cited by 551
Takikawa, O., Kuroiwa, T., Yamazaki, F., & Kido, R. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77982-4 · Cited by 472
Classification of current anticancer immunotherapies
Galluzzi, L., Vacchelli, E., Pedro, J.-M. B.-S., Buqué, A., Senovilla, L., Baracco, E. E., Bloy, N., Castoldi, F., Abastado, J.-P., Agostinis, P., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2998 · Cited by 468
Innate immunity to Toxoplasma gondii infection
Yarovinsky, F. (2014) · Nature Reviews Immunology · doi:10.1038/nri3598 · Cited by 462
The kynurenine pathway and the brain: Challenges, controversies and promises
Schwarcz, R., & Stone, T. W. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.08.003 · Cited by 461
Immunometabolism at the interface between macrophages and pathogens
Russell, D. G., Huang, L., & VanderVen, B. C. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0124-9 · Cited by 460
Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice
Ball, H. J., Sanchez-Perez, A., Weiser, S., Austin, C. J. D., Astelbauer, F., Miu, J., McQuillan, J. A., Stocker, R., Jermiin, L. S., & Hunt, N. H. (2007) · Gene · doi:10.1016/j.gene.2007.04.010 · Cited by 434
Scharton-Kersten, T. M., Yap, G., Magram, J., & Sher, A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.7.1261 · Cited by 433
Interferon-Gamma, the Activated Macrophage, and Host Defense Against Microbial Challenge
MURRAY, H. W. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-4-595 · Cited by 422
Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?
Löb, S., Königsrainer, A., Rammensee, H.-G., Opelz, G., & Terness, P. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2639 · Cited by 421
Interferon-γ: A historical perspective
Billiau, A., & Matthys, P. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.02.004 · Cited by 412
Byrne, G. I., Lehmann, L. K., & Landry, G. J. (1986) · Infection and Immunity · doi:10.1128/iai.53.2.347-351.1986 · Cited by 385
Inflammation, vitamin B6 and related pathways
Ueland, P. M., McCann, A., Midttun, Ø., & Ulvik, A. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.08.001 · Cited by 382
Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase.
Takikawa, O., Yoshida, R., Kido, R., & Hayaishi, O. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35696-x · Cited by 377
Neopterin as Marker for Activation of Cellular Immunity: Immunologic Basis and Clinical Application
(1989) · Advances in Clinical Chemistry · doi:10.1016/s0065-2423(08)60182-1 · Cited by 373
Thomas, S., Izard, J., Walsh, E., Batich, K., Chongsathidkiet, P., Clarke, G., Sela, D. A., Muller, A. J., Mullin, J. M., Albert, K., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2929 · Cited by 367
Immune response and immunopathology during toxoplasmosis
Dupont, C. D., Christian, D. A., & Hunter, C. A. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-012-0339-3 · Cited by 359
Activation of human macrophages. Comparison of other cytokines with interferon-gamma.
Nathan, C. F., Prendergast, T. J., Wiebe, M. E., Stanley, E. R., Platzer, E., Remold, H. G., Welte, K., Rubin, B. Y., & Murray, H. W. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.2.600 · Cited by 359
Ling, Y. M., Shaw, M. H., Ayala, C., Coppens, I., Taylor, G. A., Ferguson, D. J. P., & Yap, G. S. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061318 · Cited by 349
Interferon-Induced Proteins and the Antiviral State
Staeheli, P. (1990) · Advances in Virus Research · doi:10.1016/s0065-3527(08)60862-3 · Cited by 347
Haniffa, M. A., Wang, X.-N., Holtick, U., Rae, M., Isaacs, J. D., Dickinson, A. M., Hilkens, C. M. U., & Collin, M. P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1595 · Cited by 346
Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites
Moroni, F. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00196-x · Cited by 346
Immunologic basis for increased susceptibility of the neonate to infection
Wilson, C. B. (1986) · The Journal of Pediatrics · doi:10.1016/s0022-3476(86)80761-2 · Cited by 345
An expanding range of targets for kynurenine metabolites of tryptophan
Stone, T. W., Stoy, N., & Darlington, L. G. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.09.006 · Cited by 344
Toxoplasma Effectors Targeting Host Signaling and Transcription
Hakimi, M.-A., Olias, P., & Sibley, L. D. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00005-17 · Cited by 339
Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence
Beatty, W. L., Belanger, T. A., Desai, A. A., Morrison, R. P., & Byrne, G. I. (1994) · Infection and Immunity · doi:10.1128/iai.62.9.3705-3711.1994 · Cited by 338
Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated l-tryptophan metabolism
Takikawa, O. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.032 · Cited by 337
Targeting the indoleamine 2,3-dioxygenase pathway in cancer
Moon, Y. W., Hajjar, J., Hwu, P., & Naing, A. (2015) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-015-0094-9 · Cited by 336
(2013) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-53490-3.00008-x · Cited by 335
Interferon-Induced Antiviral Actions and Their Regulation
Sen, G. C., & Ransohoff, R. M. (1993) · Advances in Virus Research · doi:10.1016/s0065-3527(08)60083-4 · Cited by 334
Trial watch: IDO inhibitors in cancer therapy
Vacchelli, E., Aranda, F., Eggermont, A., Sautès-Fridman, C., Tartour, E., Kennedy, E. P., Platten, M., Zitvogel, L., Kroemer, G., & Galluzzi, L. (2014) · OncoImmunology · doi:10.4161/21624011.2014.957994 · Cited by 326
Lytic Cycle of Toxoplasma gondii: 15 Years Later
Blader, I. J., Coleman, B. I., Chen, C.-T., & Gubbels, M.-J. (2015) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091014-104100 · Cited by 312
Caldwell, H. D., Wood, H., Crane, D., Bailey, R., Jones, R. B., Mabey, D., Maclean, I., Mohammed, Z., Peeling, R., Roshick, C., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17993 · Cited by 310
Rationale for the Development of an Engineered Sporozoite Malaria Vaccine
Nussenzweig, V., & Nussenzweig, R. S. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60695-1 · Cited by 295
Indolamine 2,3‐dioxygenase is expressed in the CNS and down‐regulates autoimmune inflammation
Kwidzinski, E., Bunse, J., Aktas, O., Richter, D., Mutlu, L., Zipp, F., Nitsch, R., & Bechmann, I. (2005) · The FASEB Journal · doi:10.1096/fj.04-3228fje · Cited by 289
Reconstructing eukaryotic NAD metabolism
Rongvaux, A., Andris, F., Van Gool, F., & Leo, O. (2003) · BioEssays · doi:10.1002/bies.10297 · Cited by 280
Recruitment of Gr-1+ monocytes is essential for control of acute toxoplasmosis
Robben, P. M., LaRegina, M., Kuziel, W. A., & Sibley, L. D. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050054 · Cited by 277
Steinfeldt, T., Könen-Waisman, S., Tong, L., Pawlowski, N., Lamkemeyer, T., Sibley, L. D., Hunn, J. P., & Howard, J. C. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000576 · Cited by 276
Identification of Interferon-Stimulated Genes with Antiretroviral Activity
Kane, M., Zang, T. M., Rihn, S. J., Zhang, F., Kueck, T., Alim, M., Schoggins, J., Rice, C. M., Wilson, S. J., & Bieniasz, P. D. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.08.005 · Cited by 261
Tryptophan and indole metabolism in immune regulation
Fiore, A., & Murray, P. J. (2021) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.12.001 · Cited by 260
Invasion and intracellular survival by protozoan parasites
David Sibley, L. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00990.x · Cited by 254
Arling, T. A., Yolken, R. H., Lapidus, M., Langenberg, P., Dickerson, F. B., Zimmerman, S. A., Balis, T., Cabassa, J. A., Scrandis, D. A., Tonelli, L. H., et al. (2009) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0b013e3181c29a23 · Cited by 213
Host immune responses to Toxoplasma gondii
Sasai, M., Pradipta, A., & Yamamoto, M. (2018) · International Immunology · doi:10.1093/intimm/dxy004 · Cited by 202
IDO and Kynurenine Metabolites in Peripheral and CNS Disorders
Huang, Y.-S., Ogbechi, J., Clanchy, F. I., Williams, R. O., & Stone, T. W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00388 · Cited by 187
Quinolinic Acid Production by Macrophages Stimulated with IFN-γ, TNF-α, and IFN-α
PEMBERTON, L. A., KERR, S. J., SMYTHE, G., & BREW, B. J. (1997) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1997.17.589 · Cited by 149
“(25,26) Rubin et al. concluded that their results could be due to an indirect effect, with IFN-being produced by a subclass of cells, which in turn causes the induction of IDO .”
Blumenthal, A., Nagalingam, G., Huch, J. H., Walker, L., Guillemin, G. J., Smythe, G. A., Ehrt, S., Britton, W. J., & Saunders, B. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037314 · Cited by 105
The end of the road for the tryptophan depletion concept in pregnancy and infection
Badawy, A. A.-B., Namboodiri, A. M. A., & Moffett, J. R. (2016) · Clinical Science · doi:10.1042/cs20160153 · Cited by 92
Niedelman, W., Sprokholt, J. K., Clough, B., Frickel, E.-M., & Saeij, J. P. J. (2013) · Infection and Immunity · doi:10.1128/iai.00416-13 · Cited by 81
Lyons, R. E., Anthony, J. P., Ferguson, D. J. P., Byrne, N., Alexander, J., Roberts, F., & Roberts, C. W. (2001) · Infection and Immunity · doi:10.1128/iai.69.4.2589-2595.2001 · Cited by 79
The cross-talk between opportunistic fungi and the mammalian host via microbiota’s metabolism
Romani, L., Zelante, T., Palmieri, M., Napolioni, V., Picciolini, M., Velardi, A., Aversa, F., & Puccetti, P. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-014-0464-2 · Cited by 47
Orhan, F., Bhat, M., Sandberg, K., Ståhl, S., Piehl, F., Karolinska Schizophrenia Project (KaSP) consortium, Svensson, C., Erhardt, S., & Schwieler, L. (2016) · Scandinavian Journal of Immunology · doi:10.1111/sji.12479 · Cited by 47
Fratti, R. A., Ghannoum, M. A., Edwards, J. E., & Filler, S. G. (1996) · Infection and Immunity · doi:10.1128/iai.64.11.4714-4718.1996 · Cited by 46
Metabolites Associated With Circulating Interleukin-6 in Older Adults
Lustgarten, M. S., & Fielding, R. A. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glw039 · Cited by 44
Atlas, A., Franzen-Röhl, E., Söderlund, J., Jönsson, E. G., Samuelsson, M., Schwieler, L., Sköldenberg, B., & Engberg, G. (2013) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s13256 · Cited by 25
Wang, Y., Hu, G.-F., & Wang, Z. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s136259 · Cited by 21
“For many years, IDO has been known as an innate defense mechanism, limiting the growth of viruses, bacteria, and intracellular pathogens by consuming Trp in the local microenvironment.(21,22) IDO activity can be quantified by measuring the serum Kyn-to-Trp (Kyn/ Trp) ratio using high-performance liquid chromatography…”
Smeekens, S. P., Henriet, S. S. V., Gresnigt, M. S., Joosten, L. A. B., Hermans, P. W. M., Netea, M. G., Warris, A., & van de Veerdonk, F. L. (2012) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2011.0046 · Cited by 20
“Activation of IDO results in decreased levels of l -tryptophan, thus actively depriving invading microorganisms of an essential amino acid (Pfefferkorn 1984; Schmitz and others 1989; Hayaishi 1996).”
Peng, X., Brenner, L. A., Mathai, A. J., Cook, T. B., Fuchs, D., Postolache, N., Groer, M. W., Pandey, J. P., Mohyuddin, F., Giegling, I., et al. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.03.045 · Cited by 16
Metadata
- Authors
- Pfefferkorn, E. R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1984-02
- Volume
- 81
- Issue
- 3
- Pages
- 908-912
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1974401900
- Cited by
- 854
- References
- 11
- FWCI
- 16.26
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.